Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.012.237 |
Chemical and physical data | |
Formula | C10H14N4O2 |
Molar mass | 222.248 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Morinamide (or morphazinamide, or morinamid) is a drug used in the treatment of tuberculosis. It behaves as a prodrug for Pyrazinamide.
References
- Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- Bonanni G, Ciccariello M, Mancini P, Pace V, Sagliaschi G (1993). "Concomitant ceco-appendicular and urinary tuberculosis. Description of two rare cases: physiopathological and diagnostic remarks". Riv Eur Sci Med Farmacol. 15 (3–4): 171–4. PMID 7761665.
Antimycobacterials, including tuberculosis treatment and leprostatic agents (J04) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Nucleic acid inhibitor |
| ||||||||
Protein synthesis inhibitor |
| ||||||||
Cell envelope antibiotic |
| ||||||||
Other/unknown | |||||||||
Combinations | |||||||||
|
This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |